e-therapeutics (LON:ETX) Share Price Passes Below 200-Day Moving Average of $18.89

e-therapeutics plc (LON:ETXGet Rating) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 18.89 ($0.23) and traded as low as GBX 16.25 ($0.20). e-therapeutics shares last traded at GBX 16.75 ($0.20), with a volume of 922 shares.

e-therapeutics Trading Up 3.6 %

The stock’s fifty day simple moving average is GBX 18.61 and its two-hundred day simple moving average is GBX 18.89. The firm has a market cap of £97.50 million and a PE ratio of -9.85. The company has a quick ratio of 20.13, a current ratio of 22.64 and a debt-to-equity ratio of 2.03.

Insider Buying and Selling

In related news, insider Trevor Mervyn Jones bought 44,350 shares of the company’s stock in a transaction on Wednesday, January 4th. The shares were acquired at an average cost of GBX 17 ($0.21) per share, with a total value of £7,539.50 ($9,200.12).

e-therapeutics Company Profile

(Get Rating)

e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing.

Read More

Receive News & Ratings for e-therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.